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Background: Medicinal plants harboring endophytic fungi could carry significant potential for producing bioactive
secondary metabolites. Endophytic fungi serve as alternate source of interesting compounds in their natural and
modified synthetic forms to treat different diseases. In this regard, endophytic microflora associated with alkaloid-rich
medicinal plants Rhazya stricta is least known.
Results: We isolated one new bioactive compound sorokiniol (1) along with two known cyclic peptides BZR-cotoxin I
(2) and BZR-cotoxin IV (3) from fungal endophyte Bipolaris sorokiniana LK12. The structures of the isolated new and
known compounds were elucidated through spectroscopic data, including 1D and 2D NMR (1H, 13C, HSQC, HMBC, and
NOESY), mass, and UV. The known peptides (2–3) were characterized by ESI-MS, MS/MS, and by comparing the NMR
data with the literature. The isolated metabolites were assayed for their role against enzyme inhibition. Compound 1
was significantly inhibitory towards acetyl cholinestrase while the other compounds (2–3) had moderate anti-lipid
peroxidation and urease activities.
Conclusion: The present results suggest that the endophytic microorganism associated with indigenously important
medicinal plants can offer a rich source of biologically active chemical constituents which could help in discovering
enzyme inhibitory lead drugs.
Keywords: Endophytic fungi, Secondary metabolites, Bipolaris sorokiniana LK12, Cyclic peptides, Structure elucidation,
Enzyme inhibition and antioxidantBackground
Endophytes (bacteria or fungi) reside in the internal tissues
of plant at least once in their life cycle. This symbiosis can
be oriented towards commensalism or mutualism between
host and microbe. In this association, the plant provides a
protective sanctuary and accessibility to nutrients, whereas,
in return, the endophyte establishes a mutual relationship
with host by imparting positive effects by regulating phyto-
hormones and mineral nutrients [1]. The endophytic mi-
croorganisms secrete metabolites inside plant’s tissues to
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(http://creativecommons.org/publicdomain/ze[2–5]. Various biologically active metabolites are produced
by endophytic microorganisms such as alkaloids, steroids,
flavonoids, peptides, azaphilones, terpenoids, and phenolics
[5–7]. Schulz et al. [1] emphasized on the diversity of active
chemical constituents (~51 %) from endophytic microbes
in comparison with other soil microflora (~38 %). Cur-
rently, there have been many reports of bioactive natural
products with significantly higher anticancer, insecticidal,
and antimicrobial potentials from fungal endophytes [8].
One of the interesting examples is the production of
paclitaxel (Taxol – an anticancer drug) from endophyte
Pestalotiopsis microspora [9]. Such potential has increased
the interest to search more numbers of novel metabolites
from fungal endophytes [3, 10]. In present work, Rhazya
stricta was selected on the basis of its indigenous medi-
cinal importance whilst to explore associated endophyticle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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chemical constituents. Rhazya stricta wildly grows in vari-
ous countries of Middle Eastern regions and South Asia. It
is medicinally important plant and is famous for alkaloids
contents [11]. Approximately, 100 different kinds of alka-
loids are isolated from Rhazya stricta [12, 13]. Some of the
chemical compounds isolated from this plant have been
identified to possess strong potential in various pharmaco-
logical properties [13].
Rhazya stricta, being rich in wide array of chemical
constituents, was selected with the aim to assess the
symbiotic endophytic fungi and potential metabolites.
The endophytic wealth has not been efficiently explored
from Rhazya stricta. In a recent report we isolated fun-
gal endophyte Bipolaris sorokiniana LK12 from the leaf
parts of R. stricta [14]. This strain was characterized for
the production of bipolarisenol – a new metabolite
which is a derivative of radicinol. The metabolite was
found to significantly inhibit the activities of urease and
acetyl cholinesterase enzymes [14].
Looking at its metabolomics potential and bioactivities,
we further continued the exploration of bioactive chemical
compounds from this endophytic fungal strain. In this
regards, current study was aimed to isolate and characterize
biologically active chemical constituents produced from B.
sorokiniana LK12 through advanced chromatographic and
nuclear magnetic resonance spectroscopy techniques. The
results revealed that a new secondary metabolite, sorokiniol
(1), along with two known cyclic depsipeptides, BZR-
cotoxin I (2) and BZR-cotoxin IV (3) (Fig. 1), have been iso-
lated whilst the chemical structures were elaborated
through advanced spectral techniques. To understand any
biological role of isolated metabolites, the compounds
were assessed for their enzyme inhibition activities.
Methods
Isolation, growth and molecular identification of
endophytic fungi
The fungal endophyte B. sorokiniana LK12, isolated
from the leaf parts of Rhazya stricta was identified and
grown as described in detail by Arnold et al. [15] and byFig. 1 Structures of the isolated compounds (1–3) from fungal endophyteKhan et al. [14]. Briefly, the isolated fungus (RSL-1.2)
was grown in seven liters of Czapek broth comprising
peptone (1 %), glucose (1 %), KCl (0.05 %), FeSO4.7H2O
(0.001 %), MgSO4.7H2O (0.05 %), streptomycin (80 ppm)
and pH 7.5 ± 0.2. The cultured fungus inoculated in liquid
broth was grown on shaking incubator for twenty one
days at 28 °C. The broth was centrifuged (5,000xg at 4 °C
for 10 min) to separate the culture filtrate (CF) and my-
celia (120.4 g). Approximately, one gram of fungal cells
were lyophilized for DNA extraction, PCR analysis, and
sequencing for identification.
The fungal DNA was extracted as described Khan et al.
[14]. The fungus was identified through sequencing internal
transcribed spacer (ITS) regions. A set of universal primers
ITS-1 (5’-TCCGTAGGTGAACCTGCGG-3’) and ITS-4
(5’-TCCTCCGCTTATTGATATGC-3’) was also used to
amplify through PCR. The PCR product was sequenced by
Macrogen Inc. (Seoul, South Korea). The sequence ob-
tained was BLASTn searched (NCBI) to compare the se-
quence homology of KL12 nucleotides and with that of
related fungi using ITS regions. The homologous sequences
were aligned using Clustal W (1.6) in MEGA 6.0 [16, 17]. A
maximum parsimony tree was constructed. Bootstrap repli-
cations (1000) were used for nodes in phylogenetic tree.
The sequence was submitted to NCBI GenBank for the ac-
cession number.
Extraction and purification of compounds
The mycelial cells (120.0 g) and culture filtrate (seven li-
ters) were partitioned with equal amount of ethyl acetate
at least three times. Both extracts were dried in vacuo
and traces of water was removed by anhydrous sodium
sulfate. The dried extract was further concentrated
under reduced pressure to get 2.1 g of crude EtOAc ex-
tract. The silica gel column chromatography was per-
formed on the ethyl acetate (EtOAc) extract by using
various polarity (n-hexane/ EtOAc) solvent system,
which afforded 5 fractions; A to E. The fifth fraction (E)
was further purified through a fully preparative recycling
HPLC (High Performance Liquid Chromatography; JAI,
Japan). A continuous flow rate of 3.5 mL/min (6:4Bipolaris sorokiniana LK12
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(5.1 mg) was obtained at 23 min retention time with five
recycles.
Chromatography and spectroscopic techniques for
identification
The measurement of optical rotations was performed on
a polarimeter (JASCO DIP 360). The IR spectra were
obtained through ATR-Tensor 37 spectrophotometer by
Bruker. To record the ESI mass spectra the QSTAR XL
mass spectrometer by Applied Biosystems was used with
a capillary voltage set from 5–5.5 kV. The NMR spectra
(1H and 13C) were recorded on Bruker spectrometer op-
erating at 600 MHz (150 MHz for 13C). The δ values on
the chemical shift scale are reported in ppm, while the J
values of the coupling constants are given in Hz. Purifi-
cation of minor compounds was performed by recycling
HPLC by using a 7:3 EtOAc/n-hexane solvent system in
a silica gel column with a flow rate of 4 mL/min. Pre-
coated aluminium silica gel sheets (60 F-254, Merck)
were used for TLC (thin layer chromatography), which
were visualized under UV light at 254 and 366 nm. Ceric
sulphate and ninhydrin reagent were used for spraying
the TLC followed by heating.
Identification of the metabolites
The isolated metabolites were characterized by spectro-
scopic data (UV, IR, 1H-NMR, 13C-NMR, 2D NMR, ESI
and MS/MS studies). Compound 1 was characterized as
a new constituent, whereas compound 2 and 3 were
identified as earlier reported BZR-cotoxin I and BZR-
cotoxin IV respectively. HR-EI-MS data showed that the
molecular weight of chemical compound 1 was 374.3543
(calcd. for C26H46O 374.3549), whereas ESI-MS indi-
cated the molecular weight of compound 2 as 968.6287
[M +H]+ (calcd. for C48H86N7O13, 968.6283) and com-
pound 3 as 876.5239 [M +H]+ (calcd. for C47H70N7O9,
876.5244).
Compound 1: Pale yellow gummy solid (24.5 mg); m.p.
170–175 ° C, [α]D
30 +0.8° (CHCl3; c 0.0013,); IR υmax
(CHCl3) 3400 (OH); 2922, 1591, and 1463 (aromatic
functionalities); 1H-NMR (600 MHz, CDCl3): δ 7.21
(2H, d, J = 8.4 Hz), 6.94 (2H, d, J = 8.4 Hz), 3.67 (2H, m),
2.83 (1H, m), 2.27 (2H, m), 1.53-1.21 (16H, overlap sig-
nal), 1.29 (14H, s), 1.23 (6H, d, J = 6.1 Hz); 13C-NMR
(150 MHz, CDCl3): δ 148.7 (C-1), 139.2 (C-4), 126.9 (C-
2, C-6), 117.2 (C-3, C-5), 56.9 (C-20′), 36.9 (C-4′), 32.4
(C-5′), 31.9 (C-1′), 30.9 (C-19′), 29.2 (C-6′ to C-18′),
22.7 (C-2′, C-3′); EI-MS (m/z): 374 [M]+, 119 [M – side
chain alcohol]+; HR-EI-MS (m/z): 374.3543 (calcd. for
C26H46O 374.3549).
Compound 2: Colorless amorphous powder (4.9 mg);
IR υmax (CHCl3) 3430 (OH); 2950, 2890, 1755, 1670,
and 1645; 1H-NMR (600 MHz, CDCl3): δ 8.11 (1H, d, J =8.2 Hz, NH), 7.28 (1H, br s, NH), 5.52 (1H, d, J = 10.1 Hz),
5.43 (1H, d, J = 6.7 Hz), 5.14 (1H, d, J = 10.7 Hz), 5.06 (1H,
d, J = 10.4 Hz), 5.02 (1H, d, J = 8.5 Hz), 4.86 (2H, m), 4.71
(1H, m), 4.64 (1H, m), 4.23 (1H, br s), 3.80 (1H, br s), 3.57
(1H, dd, J = 9.8, 5.8 Hz), 3.27 (3H, s), 3.12 (3H, s),
2.93 (3H, s), 2.85 (3H, s), 1.39 (3H, d, J = 6.7 Hz),
1.25 (3H, d, J = 6.4 Hz), 2.45-1.20 (11H, m), 1.07
(3H, d, J = 6.7 Hz), 1.20-0.86 (28H, m), 0.81 (3H, d,
J = 6.4 Hz), 0.73 (3H, d, J = 6.7 Hz); HR-ESI-MS (m/z):
968.6287 [M+H]+ (calcd. for C48H86N7O13, 968.6283).
Compound 3: Amorphous powder (5.3 mg); IR υmax
(CHCl3) 3430, 2975, 2880, 1730, 1680, 1525;
1H-NMR
(600 MHz, CDCl3): δ 7.54 (1H, br s, NH), 7.38 (1H, d, J =
7.3Hz, NH), 7.35-7.17 (11H, m), 7.06 (1H, d, J = 5.6 Hz,
NH), 7.00 (1H, br s, NH), 6.69 (1H, d, J = 8.9 Hz, NH), 4.85
(1H, d, J = 5.8 Hz), 4.72 (1H, m), 4.54 (1H, t, J = 7.8 Hz),
4.34 (1H, dd, J = 7.0, 7.3 Hz), 4.05-3.85 (2H, m), 3.78 (1H,
dd, J = 4.3, 16.3 Hz), 3.68 (1H, m), 3.49-3.30 (3H, m), 3.24-
3.07 (2H, m), 3.02 (3H, s), 2.20-1.10 (10H, m), 1.03 (3H, d,
J = 7.0 Hz), 0.99 (3H, d, J = 6.7 Hz), 0.90-0.85 (12H, m), 0.79
(3H, t, J = 7.3 Hz); HR-ESI-MS (m/z): 876.5239 [M+H]+
(calcd. for C47H70N7O9, 876.5244).
Enzyme inhibition assays and anti-lipid peroxidation
The ethyl acetate extract and the three compounds were
subjected for antioxidant and enzyme suppression assay.
The inhibition potential of isolated compounds was evalu-
ated by modified thio-barbituric acid reactive substances
(TBARS) method [18]. The oxidation of liposome (phos-
phatidyl-choline, Sigma – Germany; 50 mg ml−1) was
caused by a mixture (0.200 ml) of iron chloride (FeCl3,
1 mM) and potassium chloride (KCl, 300 mM) in the pres-
ence of the sample/compound (0.050 ml). Ascorbate
(0.16 mM; 0.125 ml) was used to initiate the peroxidation.
The reaction mixture was incubated at 37 °C for 20 min.
Mixture of TBA (0.38 %) and TCA (0.750 ml 1.5:1 (v/
v) solution) was then added to the reaction mixture,
and kept on 95 °C for half an hour. The appearance of
pink color was read on ELISA microplate reader
(xMark, BioRad, USA) at 535 nm. A control without
test sample was used and the experiment was repeated
three times. The percent inhibition was measured
using formula: (1- At/Ao) x 100; where At and Ao are
the absorbance for sample, blank and standard after
30 min incubation.
The method of Golbabaei et al. [19] was used to assess
the urease enzyme (EC 3.5.1.5) inhibition activities.
Briefly, a 0.055 ml urea (100 mM) in phosphate buffer
(0.01 M LiCl2, 1.0 mM EDTA, 0.01 M K2HPO4.3H2O,
pH 8.2), 0.025 ml Jack bean Urease (2 units/mL; Sigma,
Germany), and various concentrations of the chemical
compounds (10–100 μg/mL) were combined in the reac-
tion mixture with incubation for 15 min in a 96-well
plate at 37 °C. The indophenol method was used to
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ammonia production. The alkali reagent (0.1 % NaOCl,
0.070 ml and 0.5 % sodium hydroxide) and the phenol
reagent (0.045 ml, 1 % w/v phenol and 0.005 % w/v so-
dium nitroprusside) were mixed in each well and the
change in absorbance per minute was measured after
50 min at 630 nm, by using ELISA microplate reader.
All the experiments were repeated thrice and thiourea
(10–200 μg/mL) was used as the standard inhibitor (95
± 1.50 % Inhibition). The percentage inhibition was cal-
culated by = 100 – (ODtest /ODcontrol) × 100.
Acetyl Cholinestrase Enzyme (AChE) inhibition was
measured by using a marginal modification in Ingkani-
nan et al. method [20]. In this method the substrate
acetylthiocholine iodide (ATCI, 15 mM) is hydrolysed
enzymatically to produce thiocholine, which in turn re-
acts with Ellman’s reagent (DTNB, 3 mM), which is
measured at 412 nm in ELISA microplate reader. AChE
enzyme used in the activity was obtained from electric
eel (844 U/mg protein). The stock solutions of enzyme
were kept at −80 °C. Tris–HCl buffer (0.02 M MgCl2
and 0.1 M NaCl) was used to dissolve DTNB, whereas
ATCI solution was made in deionized water.
A mixture of 20 μl of 0.25 U/ml of AChE, 40 μl of buf-
fer (50 mM Tris pH 8.0), and 100 μl of DTNB were
added along with 20 μl of different concentrations of
compounds to each well in 96-well plates. The plate was
incubated at 25 °C for 15 min. The absorbance of the re-
action mixture was read at 412 nm in ELISA spectro-
photometer (xMark BioRad, USA). The negative controlFig. 2 Phylogenetic analysis of the ITS rDNA sequence of RSL-1.2 isolated f
gies with Bipolaris sorokiniana. Aspergillus niger was used as an out-groupdid not had sample in the assay mixture. To start the re-
action, 20 μl of ATCI was added to assay mixture and
the rate of hydrolysis in acetylthiocholine read every
2 min for 20 min. All the reactions were performed
thrice and Galanthamine was used as the positive con-
trol and similar percentage inhibition formula was used
mentioned earlier for urease enzyme.Statistical analysis
The values shown are the mean of three replicates. Lin-
ear regression analysis were performed with p values
ranged to 0.05. Graphical representations were done by
using GraphPad Prism software 6.01 package (GraphPad
Software, Inc., CA, USA).Results and discussion
Endophyte identification and screening bioactivity
Endophytic fungus RSL-1.2 was identified by gDNA ex-
traction, PCR sequencing and amplification of ITS re-
gions. The phylogenetic analysis of RSL-1.2 was carried
out by using MEGA 6.0. With the help of neighbor join-
ing (NJ) and maximum parsimony (MP) methods a con-
sensus cladogram was established using 20 (19
references and 1 clone) homologues ITS sequences. Dur-
ing BLASTn search, RSL-1.2 represented the highest se-
quence homology, query coverage, and lowest E values
with B. sorokiniana. In dendrogram, RSL-1.2 formed a
99 % bootstrap level of support with B. sorokiniana
(Fig. 2). The aligned ITS sequence was deposited in therom leaves of R. stricta. The analysis showed 99 % sequence homolo-
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okiniana LK12 strain.
The EtOAc extract of the fungus B. sorokiniana
LK12 was assessed for its antioxidant capacity using
anti-lipid peroxidation, ABTS and superoxide anion
radical scavenging activities. The results shown that
the extract exhibited strong radical (superoxide anion
and ABTS) scavenging potential in comparison to
control (Additional file 1). The anti-lipid peroxidation
activity was moderate as compared to the control.Isolation and structural elucidation of secondary
metabolites
Looking at the bioactive potentials of the EtOAc extract
of endophyte, it was subjected to chromatographic stud-
ies to isolate bioactive secondary metabolites which
yielded three compounds (1–3). Compound 1 was ob-
tained in the form of pale yellow gummy solid by re-
peated chromatography experiments while using
methanol/ethyl acetate (5 %) in a silica gel column. The
molecular formula was established as C26H46O on the
basis of EI-MS (M+ at m/z 374), along with the informa-
tion obtained through 13C-NMR spectra of compound 1
(Additional file 2). The molecular formula C26H46O was
further confirmed through high resolution mass
spectrum (HR-MS), which showed the molecular ion
peak of 1 at m/z 374.3543 (calcd. for C26H46O
374.3549). The 1H-NMR spectrum of compound 1 ex-
hibited two signals for two protons each at δ 6.94 (d, J =
8.4 Hz, 2H) and 7.21 (d, J = 8.4 Hz, 2H). These coupling
constants along with the multiplicities of the aromatic
protons indicated the para-substitution of benzene ring
in compound 1. An upfield doublet for six protons at δ
1.23 (d, J = 6.1 Hz, 6H) and a multiplet for one proton at
δ 2.83 (m, 1H) were indicative of the presence of isopro-
pyl substituent at benzene ring. The second substituent
was in the form of a long chain alcohol, which was con-
firmed by the combined MS and NMR spectral data.
The down field multiplet at δ 3.67 (m, 2H) was assigned
to the methylene moiety directly attached to hydroxyl
group, whereas the signal appeared at δ 2.27 (m, 2H)Fig. 3 Key HMBC Interactions (a) and Major Mass Fragmentations (b) in Cowas assigned to the methylene group adjacent to ben-
zene ring. The other methylene groups in the chain ap-
peared between δ 1.53 and 1.21 including a singlet at δ
1.29 (s, 14H). The length of the chain was further con-
firmed by the fragments appearing in EI-MS at m/z 31,
45, 59, 73, 87, 101, 115, 129, 143, 157, 171, 185, 199,
213, 227, 241, and 255. Similarly, the presence of isopro-
pyl group and the para-substituted benzene ring was
confirmed through fragments at m/z 43, 76, and 119.
13C-NMR spectra of compound 1 (BB, DEPT) indi-
cated the presence of two signals for two sp2 carbons
each at δ 117.2, 126.9, two quaternary carbons at δ 139.2
and 148.7, an upfield signal for two methyls at δ 22.7, a
methine signal at δ 31.9, and signals for seventeen
methylene, including a downfield signal at δ 56.9, thus
supporting the para-substituted benzene ring with iso-
propyl group and an alcoholic long chain substituent.
These assignments were further confirmed by HMBC
interactions (Fig. 3) and the structure was finally con-
firmed as sorokiniol (1), after the producing organism B.
sorokiniana. Biosynthetically, compound 1 is similar in
structure to urushiol class of compounds belonging to
the plants of anacardiaceae family in the genus toxico-
dendron [21]. The biosynthesis of urushiols involves the
decarboxylation and hydroxylation reactions of anacar-
dic acid which is the product of extension of three
malonyl-CoA units with palmitoleoyl-CoA followed by
reduction and aldol cyclization [22].
Compound 2 was isolated from the crude extract
through repeated column chromatography in semi-pure
form. Further purification was done by recycling HPLC
using 7:3 EtOAc/n-hexane with a flow rate of 4 ml/min
after three recycles at an elution time of 21.3 min. Com-
pound 2 was isolated in semi-pure form at a range of
65 % to 75 % ethyl acetate/n-hexane system from the
crude extract through repeated column chromatography.
Further purification was done by recycling HPLC using
7:3 ethyl acetate/n-hexane with a flow rate of 4 ml/min
after three recycles at an elution time of 21.3 min. The
structure of compound 2 was elucidated by the com-
bined spectroscopic analyses including ESI-MS and
NMR spectroscopy. The molecular formula of secondarympound 1
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ESI-MS on the basis of pseudo-molecular ion peak at
m/z 968.6287 [M + H]+ (calcd. for C48H86N7O13,
968.6283). Moreover, the major linear peptide (Fig. 4)
was produced by the cleavage of ester bond between
serine amino acid and 2-hydroxy-3-methylbutanoic
acid. This linear peptide produced a main series of ad-
jacent yn peaks at m/z 868, 783, 683, 568, 455, 328,
215, and 88 corresponding to the successive losses of
2-hydroxy-3-methylbutanoic acid, N-methylalanine, 2-
hydroxy-3-methylbutanoic acid, N-methylthreonine,
leucine, N-methylisoleucine, N-methylvaline, and N-
methylleucine, respectively. Similarly, bn ions were de-
tected at m/z 101, 186, 401, and 754.
All these results suggested the sequence of amino
acids for the linearized peptide ion derived from BZR-
cotoxin I and thus confirmed the structure 2 for the
cyclic depsipeptide. Compound 2 showed two amide
protons and five downfield methyl signals in 1H-NMR
spectrum, whereas, nine signals for carbonyl groups
were observed in 13C-NMR spectrum. The sequence
of peptides in the molecule was further confirmed by
the HMBC analysis.
The 13C-NMR of 2 showed 48 carbon signals which was
in correlation with molecular formula, C48H85N7O13. The
DEPT experiment revealed the multiplicities while HMQC
experiments suggested the attachments of the assigned
protons. Specific resonances for peptides were observed in
1H-NMR spectrum of compound 2 in the form of broad
singlets at δ 7.97 and 7.33 ppm, which were assigned to
amide NH protons. The peptide α protons appeared in the
form of doublet of doublet and in some cases in the form
of multiplets between δ 3.19 and 4.79 ppm. The upfield sig-
nals in the region δ 0.81 to 1.27 were assigned to the me-
thyl groups of amino acids whereas the methyl groups
connected with amide nitrogen appeared between δ 2.81
and 3.36. Furthermore, the purified product had nearly
identical physical and spectral properties as those of the re-
ported cotoxin-I, which was previously reported to be pro-
duced by Bipolaris zeicola race 3 [23].
Compound 3 was also isolated in semi-pure form from
the crude extract through repeated column chromatog-
raphy at 80 % to 90 % ethyl acetate/n-hexane system.Fig. 4 Fragmentation Pattern of Protonated BZR-cotoxin I (2)The final purification was obtained through recycling
HPLC using 7:3 EtOAc/n-hexane with a flow rate of
4 ml/min after three recycles at an elution time of
25.4 min. The structure of compound 3 was elucidated
by combined ESI-MS and NMR spectral analysis. Pseudo
molecular ion peak of the protonated molecule [M +H]+
was observed at m/z 876.5239 (calcd. for C47H70N7O9,
876.5244) which was helpful to determine the molecular
formula C47H69N7O9 for compound 3. The major linear
peptide (Fig. 5) was produced by the cleavage of ester
bond between isoleucine amino acid and 2-hydroxy-3-
methylbutanoic acid. This linear peptide produced a
main series of adjacent yn peaks at m/z 776, 649, 502,
389, 332, 261, and 114 corresponding to the successive
losses of 2-hydroxy-3-methylbutanoic acid, N-methylleu-
cine, phenylalanine, isoleucine, glycine, alanine, and
phenylalanine, respectively. Similarly, bn ions were de-
tected at m/z 101, 228, 375, 488, 545, 616, and 763.
All these results suggested the sequence of amino
acids for the linearized peptide ion derived from BZR-
cotoxin IV and thus confirmed the structure 3 for the
cyclic depsipeptide. The 1H-NMR spectrum of 3 showed
six amide protons and one downfield methyl singlet.
Characteristic peptide resonances included broad sin-
glets at δ 7.31 and 7.89 ppm, which were assigned to
amide NH protons. Additional signals in the aromatic
region were assigned to the benzene ring of phenylalan-
ine amino acids. The peptide α protons appeared in the
form doublet of doublet and in some cases in the form
of multiplets between 3.92 and 4.79 ppm.
In correlation with the molecular formula
C47H69N7O9, the
13C-NMR spectrum of compound 3
contained resonances for 47 carbons including eight sig-
nals for the carbonyl groups in the downfield region.
The DEPT analysis suggested the multiplicities of carbon
resonances while HMQC analysis showed the assign-
ments of attached protons. The sequence of amino acids
in the peptide was further confirmed through HMBC
experiments. Based on the above discussion and the
comparison of the physical and spectral data with those
reported in literature, compound 3 was thus confirmed
as cotoxin-IV, which was earlier reported to be produced
by Bipolaris zeicola race 3 [24].
Fig. 5 Fragmentation Pattern of Protonated BZR-cotoxin IV (3)
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The purified compounds 1–3 were subjected to bio-
assays against acetyl cholinesterase (AChE) and urease
enzyme inhibition whilst these were also assessed for
their anti-lipid peroxidation potential. Using a concen-
tration gradient, compound 1 and 2 exhibited signifi-
cantly higher AChE enzyme inhibition as compared to
compound 3 (Fig. 6). The EC50 activity for compound 1
was 3.402 + 0.08 μg/mL (R2 = 0.89) using linear regres-
sion curve fitting with EC50 Shift in Graphpad Prism.
Compound 3 showed a dose-dependent response against
AChE enzyme inhibition. In case of urease enzyme in-
hibition, only compound 1 showed 50 % inhibition at
maximum concentration whilst other compounds (2 and
3) did not suppressed the enzyme activity (Fig. 7). A
similar pattern of low level of anti-lipid peroxidation ac-
tivity was shown by compound 3 (Fig. 8). The current
results conclude that the three compounds exhibit sig-
nificant AChE enzyme inhibition pattern.
Previously, there was no report of enzyme inhibition ac-
tivity of bioactive metabolites isolated from B. sorokiniana
LK12, however, a wide majority of fungal endophytes from
various plants have been reported to play a vital role againstFig. 6 Enzyme Acetyl Cholinesterase inhibition activities of
compound 1 – 3. The graphical lines shows standard error of means
of three replicationssuppression of enzymatic disorders. Antioxidant activities
are frequently investigated for endophytes (e.g., Botryo-
sphaeria dothidea and Aspergillus awamori) isolated from
medicinal plants (Melia azedarach L. and Rauwolfia ser-
pentina Benth, respectively) [8, 25]. Liu et al. [26] isolated
Xylaria sp. from the stem of ancient medicinal plant Ginkgo
biloba and studied the potential of this species to produce
antioxidants, where the organism exhibited a strong radical
scavenging activity. Similarly, Huang et al. [27] investigated
the total antioxidant and total phenolic contents of a re-
pository of 292 endophytes from 29 traditional Chinese me-
dicinal plants using improved ABTS methods. Similarly,
Rodrigues et al. [28] and Xiao et al. [29] suggested various
endophytic fungi from different host plants can show po-
tent source of essential enzyme inhibition activities such as
AChE inhibition.
On the other hand, alzheimer’s disease, for which
AChE inhibition emerged as the major therapeutic tar-
get, only approved drug is galantamine [28]. We used
this to compare our results, which were very encour-
aging; however, further studies at molecular level would
be needed to get more insight of receptors involved in
the inhibition of AChE [29]. The present results alsoFig. 7 Enzyme Urease inhibition activities of compound 1 – 3. The
graphical lines shows standard error of means of three replications
Fig. 8 Anti-Lipid Peroxidation activities of compound 1 – 3. The
graphical lines shows standard error of means of three replications
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ally active medicinal plants also carries interesting bioac-
tivities which could help in discovering lead drugs.
Conclusion
The present results showed that fungal endophyte associ-
ated with medicinal plants can possess a potent ability to
secrete biologically active metabolites. In current case, B.
sorokiniana LK12 produced a new compound, sorokiniol
along with two known cyclic peptides BZR-cotoxin I and
BZR-cotoxin IV. The chemical constituents exhibited sig-
nificantly inhibitory effects towards acetyl cholinestrase
while moderate urease and anti-lipid peroxidation activities.
Further studies at broader enzyme kinetics level could fur-
ther help in understanding the enzyme inhibitory role of
chemical constituents isolated from endophytes.
Additional files
Additional file 1: Figure S1. Antioxidant activity of the ethyl acetate
extract (1.0 mg/mL) of the B. sorokiniana LK12. ABTS, LPO – anti-lipid
peroxidation; O2- superoxide anion. Bars shows standard error of five
replicates of each activity. For positive control, ascorbic acid was use.
(DOC 824 kb)
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Abbreviations
AChE, acetyl cholinestrase; DDW, deionized distilled water; HPLC, recycling
preparative High Performance Liquid Chromatography; ITS, culture medium
(culture filtrate–CF), internal transcribed regions; MP, maximum parsimony;
NJ, neighbor joining; PDA, potato dextrose agar; TBARS, thiobarbituric acid
reactive substances; TLC, thin layer chromatography
Acknowledgements
The authors acknowledge the efforts of Khadija Al-Hosni and Salima Al-Khiziri
for isolating the microorganism.
Funding
This work was financially supported by National Research Foundation of
Korea (NRF), Ministry of Science, ICT and Future-Planning through Basic-
Science Research Program (2014R1A1A2A10058022) and The Oman Research
Council (FURAP Program).Availability of data and materials
Data supporting the findings is contained within the manuscript.
Phylogenetic analysis of the ITS rDNA sequence of RSL-1.2 isolated from
leaves of R. stricta. The gDNA sequence of Bipolaris sorokiniana LK12 was
submitted to NCBI and are available under the accession No KP715347. The
phylogenetic tree of LK12 fungal strain was deposited in TreeBase (ID:
19351). The strain is available on request with ALK at Biotechnology &
Microbiology lab, UoN Chair of Oman’s Medicinal Plants & Marine Natural
Products, University of Nizwa, 616, Nizwa, Sultanate of Oman.
Authors’ contributions
LA and ALK designed, and performed the experiments, while SMK, and MW
undertook endophyte identification and phylogenetic analysis. JH, AA and
AA edited the work. IJL and AA financially supported the work. All authors
read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent to publish
Not applicable.
Ethics approval and consent to participate
Not applicable.
Author details
1UoN Chair of Oman’s Medicinal Plants and Marine Natural Products,
University of Nizwa, Nizwa 616, Sultanate of Oman. 2Department of
Biological Sciences and Chemistry, College of Arts and Sciences, University of
Nizwa, Birkat Al-Mouz, Nizwa 616, Sultanate of Oman. 3School of Applied
Biosciences, Kyungpook National University, Daegu 41566, Republic of Korea.
4Department of Agriculture, Abdul Wali Khan University, Mardan, Pakistan.
Received: 22 March 2015 Accepted: 1 June 2016
References
1. Schulz B, Boyle C, Draeger S, Römmert K, Krohn K. Endophytic fungi:
a source of novel biologically active secondary metabolites. Mycol Res.
2002;106:996–1004.
2. Guo B, Wang Y, Sun X, Tang K. Bioactive natural products from endophytes:
a review. Appl Biochem Microbiol. 2008;44:136–42.
3. Kusari S, Hertweck C, Spiteller M. Chemical ecology of endophytic fungi:
origins of secondary metabolites. Chem Biol. 2012;19(7):792–8.
4. Li XJ, Zhang Q, Zhang AL, Gao JM. Metabolites from Aspergillus fumigates,
an endophytic fungus associated with Melia azedarach, and their antifungal,
antifeedant, and toxic activities. J Agric Food Chem. 2012;60(13):3424–31.
5. Khan AL, Hussain J, Al-Harrasi A, Al-Rawahi A, Lee IJ. Endophytic fungi: a
source of gibberellins and crop resistance to abiotic stress. Crit Rev Biotech.
2013;35(1):62–74.
6. Schulz B, Boyle C. The endophytic continuum. Mycol Res. 2005;109:661–86.
7. Kaul S, Gupta S, Ahmed M, Dhar MK. Endophytic fungi from medicinal
plants: a treasure hunt for bioactive metabolites. Phytochem Rev.
2012;11(4):487–505.
8. Xiao J, Zhang Q, Gao YQ, Tang JJ, Zhang AL, Gao JM. Secondary
metabolites from the endophytic Botryosphaeria dothidea of Melia
azedarach and their antifungal, antibacterial, antioxidant, and cytotoxic
activities. J Agric Food Chem. 2014;62(16):3584–90.
9. Tan RX, Zou WX. Endophytes: a rich source of functional metabolites. Nat
Prod Rep. 2001;18:448–59.
10. Strobel G, Daisy B, Castillo U, Harper J. Natural products from endophytic
microorganisms. J Nat Prod. 2004;67:257–68.
11. Zaman K, Perveen S, Muzaffar A, Choudhary MI, Pervin A. Alkaloids from
Rhazya stricta. Phytochemistry. 1991;30:1285–93.
12. Gilani SA, Kikuchi A, Shinwari ZK, Khattak ZI, Watanabe KN. Phytochemical,
pharmacological and ethnobotanical studies of Rhazya stricta Decne.
Phytother Res. 2007;4:301–7.
13. Ali BH, Al-Qarawi A, Bashir AK, Tanira M. Phytochemistry, pharmacology and
toxicity of Rhazya stricta Decne: A review. Phytother Res. 2000;14:229–34.
Ali et al. BMC Microbiology  (2016) 16:103 Page 9 of 914. Khan AL, Ali L, Hussain J, Rizvi TS, Al-Harrasi A, Lee IJ. Enzyme inhibitory
Radicinol Derivative from Endophytic fungus Bipolaris sorokiniana LK12,
Associated with Rhazya stricta. Molecules. 2015;20(7):12198–208.
15. Arnold AE, Lutzoni F. Diversity and host range of foliar fungal endophytes:
are tropical leaves biodiversity hotspots? Ecology. 2007;88(3):541–9.
16. Torres MS, White Jr JF, Zhang X, Hinton DM, Bacon CW. Endophyte-
mediated adjustments in host morphology and physiology and effects on
host fitness traits in grasses. Fungal Ecol. 2012;5:322–30.
17. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5:
Molecular evolutionary genetics analysis using maximum likelihood,
evolutionary distance, and maximum parsimony methods. Mol Biol Evol.
2011;28:2731–9.
18. Gulati V, Harding IH, Palombo EA. Enzyme inhibitory and antioxidant
activities of traditional medicinal plants: Potential application in the
management of hyperglycemia. BMC Comp Alter Med. 2012;12:77.
19. Golbabaei S, Bazl R, Golestanian S, Nabati R, Omrany RB, Yousefi B, et al.
Urease inhibitory activities of β-boswellic acid derivatives. DARU J Pharm
Sci. 2013;21:2.
20. Ingkaninan K, Temkitthawon P, Chuenchom K, Yuyaem T, Thongnoi W.
Screening for acetylcholinesterase inhibitory activity in plants used in
Thai traditional rejuvenating and neurotonic remedies. J Ethnopharmacol.
2003;89:261–4.
21. Barceloux DG. Medical Toxicology of Natural Substances: foods, fungi,
medicinal herbs, plants, and venomous animals. NJ Hoboken eds: John
Wiley & Sons; 2008.
22. Dewick PM. Medicinal Natural Products: A Biosynthetic Approach, 2nd eds.,
New Jersey, USA: John Wiley & Sons; 2002.
23. Ueda K, Xiao J-Z, Doke N, Nakatsuka S-I. Structure of BZR-cotoxin I Produced
by Bipolaris zeicola race 3, the Cause of Leaf Spot Disease in Corn. Tet Lett.
1994;35:7033–6.
24. Ueda K, Xiao J-Z, Doke N, Nakatsuka S-I. Isolation and Structure of
BZR-cotoxin IV produced by Bipolaris zeicola race 3, the cause of leaf
spot disease in corn. Tet Lett. 1995;36:741–4.
25. Nath A, Chattopadhyay A, Joshi SR. Biological activity of endophytic fungi of
Rauwolfia serpentina Benth: an ethnomedicinal plant used in folk medicines
in Northeast India. Proc Nat Acad Sci, India Sect B: Biol Sci. 2015;85(1):233–40.
26. Liu X, Mingsheng D, Chen X, Jiang M, Liu C, Yan G. Antioxidant activity and
phenolics of an endophytic Xylaria sp. from Ginkgo biloba. Food Chem.
2007;105:548–54.
27. Huang WY, Cai YZ, Xing J, Corke H, Sun M. A potential antioxidant resource:
endophytic fungi from medicinal plants. Econ Bot. 2007;61:14–30.
28. Rodrigues KF, Costa GL, Carvalho MP, Epifanio RDA. Evaluation of extracts
produced by some tropical fungi as potential cholinesterase inhibitors.
World J Microbiol Biotech. 2005;21:1617–21.
29. Xiao ZE, Huang H, Shao C, Xia X, Ma L, Huang X, et al. Asperterpenols A and
B, new sesterterpenoids isolated from a mangrove endophytic fungus
Aspergillus sp. 085242. Org Lett. 2013;15:2522–5.•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
